NAS10026,946−5.25%S&P7,428−3.39%GOLD$4,132+1.46%BTC$75,633−5.94%VIX23.84+43.53%latest tape · as of 18:03 UTC
The Screen · Energy · Oil & Gas Refining & Marketing
VLOValero Energy
VLO · a US exchange · USD · Market cap $107.3B · 9,785 employees
Valero Energy Corporation manufactures, markets, and sells petroleum-based and low-carbon liquid transportation fuels and petrochemical products in the United States, Canada, the United Kingdom, Ireland, Latin America, M…
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.54, read 2026-11-05
Ethical passes the values gate
Price365.34 USD
Fair value446.51
Ethical score85.9/100
Value readUndervaluedas of 4 Nov 2026
Our investment reviews on this name
2026-11-05Read Distribution365.34+0.0% to today Markup gives way to Distribution after a 6% slide in 4 weeks
2026-10-11Read Markup387.18-5.6% to today Accumulation gives way to Markup after a 13% rise in 6 weeks
2026-08-30Read Accumulation341.51+7.0% to today ✓Markup gives way to Accumulation after a 33% rise in 8 weeks
2026-07-02Read Markup255.82+42.8% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Valero Energy holds its Distribution at $365.34. Consolidating, no directional conviction, held for 111 days.
As held on the ledger · 2026-11-04
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 111 days
Price at the screen
$365.34
Valuation
8.75 trailing · 7.17 forward price to earnings
Values screen
PASS· score 85.9
Beta
0.59
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
20.18%
Below 33%
Interest-bearing debt is just 20.2% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
1.18%
Below 33%
Cash held in interest-bearing accounts and securities is 1.2% of assets, under the one-third limit.
Pass
Receivables
23.96%
Below 49%
Money owed to the company is 24.0% of assets, under the 49% limit.
Pass
Revenue purity
0.20%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Valero Energy clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 20%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when VLO's ethical verdict changes
Today VLO passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Conscience flag · AFSC Investigate, American Friends Service Committee
The quantitative screen above is arithmetic and this name passes it. Separately, community boycott lists cite this company: Documented on AFSC Investigate / American Friends Service Committee — category: Weapons. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 4 Nov 2026: it trades at roughly an 18% discount to our $446.51 fair value, weak competitive moat, 51.90% revenue growth.
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 18.2% discount to the base estimate.
Where our models see it going: fair-value estimate $446.51, with a range of $339.76 to $566.27, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Refiner looks tempting on paper alone
Picture a plant turning crude into petrol while oil prices rollercoaster every quarter. That is the daily reality for this refiner.
It stands out on a forward multiple of 13.9 times, 7 percent revenue growth, 4 percent margins and 16 percent return on equity. The ethical screen clears it and the analyst crowd leans buy toward 288 dollars.
Refining is deeply cyclical, so the low multiple often flags peak earnings rather than a bargain. Shares sit 23 percent above our fair value of 237.94 dollars. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
VLO trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 50% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (19 analysts) rates it buy, with a mean price target of $256.
2026-10-29Markup$388.48-12.5%Entry 22
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 12.5% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 50% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (19 analysts) rates it buy, with a mean price target of $256.
2026-10-22Markup$444.06+0.0%Entry 21
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (19 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Markup$444.06+0.0%Entry 20
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (19 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Markup$444.06+0.0%Entry 19
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (19 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Markup$444.06+0.0%Entry 18
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (19 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markup$444.06+0.0%Entry 17
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (19 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-17Markup$444.06+0.0%Entry 16
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (19 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16Markup$444.06+2.4%Entry 15
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.4% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (19 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-15Markup$433.75+12.0%Entry 14
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 12.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 101%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (19 analysts) rates it buy, with a mean price target of $256. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.